Comparing Neulasta vs Udenyca
| Neulasta (pegfilgrastim) | Udenyca (pegfilgrastim) |
|
|---|
| Neulasta (pegfilgrastim) | Udenyca (pegfilgrastim) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Neulasta injection is a prescription medicine that may be given once every chemotherapy cycle to prevent febrile neutropenia in those people at high risk of it because of cancer treatments they are... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Febrile Neutropenia, Neutropenia Associated with Radiation, Hematopoietic Syndrome of Acute Radiation Syndrome. Udenyca may also be used for... View more |
Related suggestions Neutropenia Associated with Chemotherapy
Febrile Neutropenia
Hematopoietic Syndrome of Acute Radiation Syndrome
Neutropenia Associated with Radiation
Popular comparisons
|
|||||||
| More about Neulasta (pegfilgrastim) | More about Udenyca (pegfilgrastim) | ||||||||
| Ratings & Reviews | |||||||||
|
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
Udenyca has an average rating of 2.5 out of 10 from a total of 4 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 75% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Neulasta side effects |
View all Udenyca side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Udenyca prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other pegfilgrastim brands include: Fulphila, Fylnetra, Neulasta, Nyvepria, Stimufend, Ziextenzo | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
80 hours |
80 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 178 drugs are known to interact with Neulasta:
|
A total of 178 drugs are known to interact with Udenyca:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 31, 2002 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.